Skip to main content
. 2019 Dec;69(6):468–489. doi: 10.30802/AALAS-CM-19-000048

Table 9.

Rat efficacy studies of buprenorphine

Dose (mg/kg) Route Test Duration of action Comments Reference
0.01 IM Lap, TF No effect Dosed q12h for 72 h 41
0.1 IM Lap, TF Dosed q12h for 72 h. BW and food intake similar to saline treatment; TF increased latency 41
0.02-0.2 IP TF 24 h at 0.2 mg/kg Hyperalgesia at 0.01 mg/kg 207
8 µg/kg IV TF 4 h 161
0.4 PO Lap 270-390 min Observations limited to 390 min postoperative 176
0.5-10 PO-G TF 2 h at 5-10 mg/kg 138
0.5 PO-G HP 3-5 h 129
0.1-0.4 PO-J Lap Increased BW all treatment groups 62
0.5 PO-J HP 1 h 129
0.5 PO-J Lap Dosed q12h for 36 h. Not effective based on BW 98
0.5- 2.0 PO-N HP 60-120 at 1 mg/kg 92
0.4 PO-N SX No change in corticosterone; no change in activity 5h post op; BW loss less than control 72
0.3-3.0 SC HP, TF ED50 0.4 mg/kg 206
0.03 SC Lap Dosed q12h for 72 h. Decrease BW 20
0.03 SC PW 24 h Reduce RGS 133
0.05 SC SX Dosed q8-12h for 120 h. Improved gait 27
0.05 SC HP, SX, VF No effect Dosed q12h for 72 h 34
0.05 SC HP 1 h 107
0.05 SC SX No effect Dosed preoperative and 18 h postoperative supplemented with 0.25 mg/kg POJ 117
0.05 SC HP 3-5 h 129
0.05 SC 2 h 138
0.05 SC HP Dosed q12h for 60 h. PW latency increased; Minimal effect 141
0.05 SC Lap 270-390 min postoperative Observations limited to 390 min postoperative 176
0.05 SC SX, VF, HP Up to 96 h Dosed q12h for 72 h. Reduced mechanical and thermal sensitivity. 184
0.05 SC Lap Lower ethogram score 160
0.1 SC FT 6 h 1
0.1 SC HP 30-240 min 92
0.1 SC Lap Dosed q12h for 72 h. Lower ethogram score 160
0.25-0.1 SC VF Increase threshold 196
0.2 SC PW, SX PW no effect at 24h; no effect on vertical rises 64
0.5 SC SX Increase corticosterone levels 72
0.5 SC SX No effect Supplemented with 0.25 mg/kg POJ 117
0.5 SC HP, TF 6-8 h 66
0.3 SRzp SC HP, SX, VF No effect 34
0.65 SRzp SC HP 4-48 h 107
1.2 SRzp SC HP, SX, VF HP increase latency at 24h; VF no significant difference to baseline 34
1.2 SRzp SC SX, PW Up to 48 h Increase vertical rises compared with buprenorphine 64
1.2 SRzp SC HP 24-72h 107
1.2 SRzp SC SX, VF, HP Up to 96 h Reduced mechanical and thermal sensitivity. 184
1.2 SRzp SC Lap Dosed q12h for 72 h. Lower ethogram score 160
4.5 SRzp SC HP, SX, VF HP increased latency at 24 h at 4.5 mg/kg; VF no effect; Sedative effect with 4.5 mg/kg 34

Effects are based on a single dose of analgesic unless otherwise described in the comments.

PO-n = oral in Nutella; PO-J = oral in gelatin; PO-G = oral by gavage

SX = surgical model; Lap = Laparotomy

HP = hot plate assay; PW = paw withdrawal test; TF = tail-flick assay; VF = von Frey test

zP = manufactured by Zoopharm, Windsor, CO